These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15543620)

  • 1. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.
    Wikman H; Nymark P; Väyrynen A; Jarmalaite S; Kallioniemi A; Salmenkivi K; Vainio-Siukola K; Husgafvel-Pursiainen K; Knuutila S; Wolf M; Anttila S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):193-9. PubMed ID: 15543620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
    Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
    Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
    Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP
    Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer.
    Simon R; Struckmann K; Schraml P; Wagner U; Forster T; Moch H; Fijan A; Bruderer J; Wilber K; Mihatsch MJ; Gasser T; Sauter G
    Oncogene; 2002 Apr; 21(16):2476-83. PubMed ID: 11971182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
    Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
    Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
    Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
    Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
    Khatib ZA; Matsushime H; Valentine M; Shapiro DN; Sherr CJ; Look AT
    Cancer Res; 1993 Nov; 53(22):5535-41. PubMed ID: 8221695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
    Ruano Y; Mollejo M; Ribalta T; Fiaño C; Camacho FI; Gómez E; de Lope AR; Hernández-Moneo JL; Martínez P; Meléndez B
    Mol Cancer; 2006 Sep; 5():39. PubMed ID: 17002787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of gene amplification by genomic hybridization to cDNA microarrays.
    Heiskanen MA; Bittner ML; Chen Y; Khan J; Adler KE; Trent JM; Meltzer PS
    Cancer Res; 2000 Feb; 60(4):799-802. PubMed ID: 10706083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors.
    Louis-Brennetot C; Coindre JM; Ferreira C; Pérot G; Terrier P; Aurias A
    Genes Chromosomes Cancer; 2011 Nov; 50(11):896-907. PubMed ID: 21910158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
    Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma.
    Fischer U; Keller A; Leidinger P; Deutscher S; Heisel S; Urbschat S; Lenhof HP; Meese E
    Mol Cancer Res; 2008 Apr; 6(4):576-84. PubMed ID: 18403636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
    Ichimura K; Schmidt EE; Goike HM; Collins VP
    Oncogene; 1996 Sep; 13(5):1065-72. PubMed ID: 8806696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins.
    Ramirez RD; Sheridan S; Girard L; Sato M; Kim Y; Pollack J; Peyton M; Zou Y; Kurie JM; Dimaio JM; Milchgrub S; Smith AL; Souza RF; Gilbey L; Zhang X; Gandia K; Vaughan MB; Wright WE; Gazdar AF; Shay JW; Minna JD
    Cancer Res; 2004 Dec; 64(24):9027-34. PubMed ID: 15604268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation.
    An HX; Beckmann MW; Reifenberger G; Bender HG; Niederacher D
    Am J Pathol; 1999 Jan; 154(1):113-8. PubMed ID: 9916925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
    Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.